Literature DB >> 9600681

Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis.

A Rösler1, M Pohl, H J Braune, W H Oertel, D Gemsa, H Sprenger.   

Abstract

Chemokines (chemoattractant cytokines) attract and activate specific leukocyte subsets. With regard to their expression by brain parenchymal cells, they may represent the key molecules that control leukocyte entry into the subarachnoid space. In order to evaluate the contribution of chemokines in vivo, we determined the levels of MCP-1, MIP-1alpha, RANTES, IL-8, as well as of the sIL-2R in three patients with proven herpes simplex encephalitis type 1 (HSE-1). CSF samples were drawn by a subarachnoid catheter system throughout the time course of hospitalisation. Results were compared to chemokine levels in serum drawn in parallel. The clinical status was documented by the Modified Barthel Index and correlated with chemokine levels in the CSF. The results were compared with the chemokine levels in the CSF of 17 control patients with normal CSF routine parameters. High chemokine levels were detectable in the CSF of all HSE-patients. MCP-1 peak levels were found at the time of admission, while maximal IL-8 levels occurred 4 to 8 h later. The levels of MIP-1alpha and RANTES were lower than those of MCP-1 with a maximum at the time of admission. In all patients the levels of the sIL-2R increased later in the time course, at 14 to 20 h after admission. When the levels of MCP-1 were compared with the clinical status by Modified Barthel Index, we found a high reciprocal correlation (r=-0.82). Routine CSF parameters, such as leukocytes, albumin and immunoglobulins did not correlate with the clinical status. Chemokine levels in serum were found to be close to the detection limits of the ELISA systems. Our data suggest that chemokines play an important role in the pathogenesis of HSE. They may be useful parameters to monitor the stage and severity of the disease. The late increase of sIL2-R levels may indicate the beginning of the reconstitution phase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600681     DOI: 10.1016/s0022-510x(98)00061-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  Viral and inflammatory triggers of neurodegenerative diseases.

Authors:  Michela Deleidi; Ole Isacson
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

3.  The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.

Authors:  Benedict Daniel Michael; Michael J Griffiths; Julia Granerod; David Brown; Geoff Keir; Małgorzata Wnęk; Daniel J Cox; Rishma Vidyasagar; Ray Borrow; Laura M Parkes; Tom Solomon
Journal:  J Infect Dis       Date:  2015-12-27       Impact factor: 5.226

Review 4.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

5.  Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Authors:  Márcia Carvalho Vilela; Graciela Kunrath Lima; David Henrique Rodrigues; Norinne Lacerda-Queiroz; Vinicius Sousa Pietra Pedroso; Aline Silva de Miranda; Milene Alvarenga Rachid; Erna Geessien Kroon; Marco Antônio Campos; Mauro Martins Teixeira; Antonio Lucio Teixeira
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-19       Impact factor: 4.147

6.  Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Anders Hjalmarsson; Fredrik Granath; Marianne Forsgren; Maria Brytting; Paul Blomqvist; Birgit Sköldenberg
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

7.  Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis.

Authors:  Cristina P Marques; Maxim C-J Cheeran; Joseph M Palmquist; Shuxian Hu; Stina L Urban; James R Lokensgard
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  ICAM-5 modulates cytokine/chemokine production in the CNS during the course of herpes simplex virus type 1 infection.

Authors:  Margaret C L Tse; Crystal Lane; Kevin Mott; Nattawat Onlamoon; Hui-Mien Hsiao; Guey Chuen Perng
Journal:  J Neuroimmunol       Date:  2009-07-09       Impact factor: 3.478

9.  Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria.

Authors:  Chandy C John; Angela Panoskaltsis-Mortari; Robert O Opoka; Gregory S Park; Paul J Orchard; Anne M Jurek; Richard Idro; Justus Byarugaba; Michael J Boivin
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

10.  Defining the chemokine basis for leukocyte recruitment during viral encephalitis.

Authors:  Daniela Michlmayr; Clive S McKimmie; Marieke Pingen; Ben Haxton; Karen Mansfield; Nicholas Johnson; Anthony R Fooks; Gerard J Graham
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.